In terms of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed the Notice of 21st Annual General Meeting and Integrated Annual Report of financial year 2024-25 including Business Responsibility and Sustainability Report of the Company. The 21st Annual General Meeting of the Company will be held on Friday, 18th July, 2025 at 11.00 am (IST) through Video Conference/ Other Audio-Visual Means. The Integrated Annual Report containing said notice of the company is also available on the Company’s website and can be accessed at https://www.akums.in/annualreport/integrated-annual-report-2024-25.pdf.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.35 |
| Dr. Reddys Lab | 1220.80 |
| Cipla | 1236.00 |
| Zydus Lifesciences | 928.80 |
| Lupin | 2313.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: